BOSTON, Sept. 30, 2024 -- Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today...
Eric Linsley will co-chair the CED's 25th Annual Venture Conference in Durham, NC
News | 04. 16. 2008
